Brain Impairment, published by Cambridge University Press, is a pivotal academic journal dedicated to advancing the understanding of neurological conditions and cognitive processes. With its ISSN 1443-9646 and E-ISSN 1839-5252, this esteemed journal has been at the forefront of research in the fields of Behavioral Neuroscience, Cognitive Neuroscience, and Neuropsychology since its inception in 2004. Covering a broad scope, it addresses critical insights into brain function, impairments, and therapies, making it a valuable resource for researchers, clinicians, and students alike. Brain Impairment holds various rankings, including Q4 in Behavioral Neuroscience and Q2 in Speech and Hearing, reflecting its significance in the academic community. While the journal operates under print access, its rich content serves as an essential reference for professional development and scholarly discussion in the UK and beyond. Researchers and practitioners can rely on this journal to provide cutting-edge research and reviews that inform clinical practice and shape future studies in neurology and cognitive neuroscience.

The Breast Journal, published by Wiley-Hindawi, is a distinguished Open Access journal dedicated to the fields of internal medicine, oncology, and surgery with a particular focus on breast health and disease. Since its inception in 1995, the journal has become an essential resource for researchers and clinicians, facilitating the dissemination of high-quality research and innovative clinical practices. With an impact factor reflecting robust scholarly influence and a ranking in the Q3 quartile for both internal medicine and oncology, as well as Q2 in surgery, it showcases significant contributions that advance knowledge and improve patient outcomes. Offering unparalleled access to its articles, The Breast Journal aims to support a global audience in exploring the multifaceted challenges and breakthroughs in breast-related health, making it a vital platform for shared learning and scientific discourse.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, published by Lippincott Williams & Wilkins, is a leading journal in the field of cardiovascular medicine, dedicated to the advancement of research surrounding arterial diseases, thrombosis, and vascular biology. With an impressive impact factor indicative of its reach and influence, this journal occupies a prominent position in the Q1 category of cardiology, ranking 13th out of 387 in its field according to Scopus, placing it within the top 96th percentile among cardiovascular research journals. Since its inception in 1990, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY has been pivotal in disseminating cutting-edge research that drives innovation and education in cardiovascular health. Although it does not operate under an open access model, the journal is a vital resource for researchers, clinicians, and students looking for high-quality, peer-reviewed articles that contribute to the understanding and treatment of cardiovascular and vascular disorders. Its commitment to rigorous scientific standards and its focus on impactful findings make it an essential publication for anyone dedicated to the field.

Dementia and Geriatric Cognitive Disorders Extra, published by KARGER in Switzerland, is an esteemed open-access journal dedicated to advancing research in the fields of cognitive neuroscience, geriatrics, and psychiatry. With a commitment to disseminating high-quality research since its inception in 2011, the journal plays a crucial role in highlighting innovative studies that address cognitive disorders associated with aging. As an open-access platform, it ensures that findings are accessible to a global audience, fostering collaboration and knowledge-sharing among researchers, professionals, and students alike. The journal has been recognized for its impact in Cognitive Neuroscience and Psychiatry and Mental Health, achieving a Q3 category ranking, indicating its reputable standing within these fields. By delivering cutting-edge insights and promoting interdisciplinary approaches, Dementia and Geriatric Cognitive Disorders Extra is instrumental in enhancing understanding and treatment of cognitive decline, making it a vital resource for anyone engaged in the study of aging and cognitive health.

Welcome to the International Journal of Sports Physical Therapy, a premier platform dedicated to advancing the field of sports therapy and rehabilitation. Published by the NORTH AMER SPORTS MEDICINE INST-NASMI, this open access journal has been vital in disseminating state-of-the-art research since its inception in 2011. With an ISSN of 2159-2896, it boasts a commendable standing within the academic community, achieving a Q2 ranking in 2023 across multiple categories, including Orthopedics and Sports Medicine, Physical Therapy, and Rehabilitation. Spanning diverse topics relevant to sports physical therapy, this journal serves as an invaluable resource for researchers, clinicians, and students alike, promoting best practices and innovative techniques in the field. By maintaining a commitment to high-quality peer-reviewed content, it not only contributes significantly to the existing body of knowledge but also fosters collaboration among professionals seeking to enhance patient care and rehabilitation outcomes.

Cardiology in Review, published by Lippincott Williams & Wilkins, is a prominent journal focused on advancing the field of cardiology and cardiovascular medicine. With a history of publication spanning from 1995 to 2024, the journal serves as an essential resource for researchers, healthcare professionals, and students alike, offering in-depth reviews and analyses on the latest developments, clinical practices, and research findings in cardiology. Despite being a traditional print journal, it maintains a commendable Q2 ranking in both cardiology and miscellaneous medicine categories as of 2023, reflecting its influence and rigor in the academic community, with a Scopus rank of #132 out of 387 in its field, placing it in the 66th percentile. The journal aims to bridge the gap between clinical practice and emerging research, promoting a deeper understanding and integration of innovative strategies in cardiovascular care. With its commitment to high-quality scholarship, Cardiology in Review remains a vital conduit for knowledge and dialogue within the evolving landscape of cardiovascular health.

Frontiers in Cardiovascular Medicine is a leading open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing research in the field of cardiology and cardiovascular medicine. Since its inception in 2014, the journal has become a vital platform for the dissemination of high-quality research, boasting a commendable Q2 rank in the 2023 category for Cardiology and Cardiovascular Medicine. With a focus on promoting innovative studies and clinical insights, Frontiers in Cardiovascular Medicine facilitates open access to its content, allowing researchers, healthcare professionals, and students from around the globe to engage with the latest findings which are critical for the advancement of cardiovascular health. The journal's significant presence in the academic landscape, as indicated by its Scopus ranking (161/387 and 58th percentile), underscores its importance as a research outlet in this essential field. Located in Lausanne, Switzerland, the journal continues to support the global cardiovascular community by encouraging collaboration and knowledge sharing to address the challenges faced in cardiovascular medicine today.

Metabolic Syndrome and Related Disorders is an esteemed journal published by MARY ANN LIEBERT, INC, focusing on the multifaceted aspects of metabolic syndrome, including its interaction with chronic diseases such as diabetes, cardiovascular conditions, and obesity. Since its inception in 2003, this journal has established itself as a vital resource for researchers, healthcare professionals, and students dedicated to advancing knowledge in the fields of endocrinology, internal medicine, and metabolic disorders. With an impact factor reflective of its academic significance, Metabolic Syndrome and Related Disorders is recognized within the Q2 and Q3 quartiles in its respective categories, solidifying its reputation among scientific and clinical communities. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and reviews that foster innovative solutions and improve patient outcomes. The journal's gradual convergence towards 2024 presents an exciting opportunity for continued exploration and dialogue about metabolic-related health challenges.

Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.

HEART RHYTHM is a leading academic journal published by Elsevier Science Inc, focusing on cutting-edge research in the field of cardiology and cardiovascular medicine. Established in 2004 and continuing its impactful journey through 2024, this journal holds an esteemed position within the academic community, boasting a 2023 Q1 ranking in both Cardiology and Cardiovascular Medicine and Medical Physiology, indicating its significant influence and contribution to these areas of study. With a commendable Scopus ranking—ranked #34 out of 387 in Cardiology and #11 out of 113 in Physiology—HEART RHYTHM is recognized for publishing high-quality research that drives advancements in understanding heart rhythms and associated medical conditions. Although it does not support open access, the journal remains accessible to professionals, researchers, and students, serving as a vital resource for the latest findings and theories in cardiovascular health. Invested in the mission to enhance knowledge and improve clinical practices, HEART RHYTHM stands as an essential publication for those aspiring to excel in the fields of cardiology and cardiovascular research.